Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-surgical atorvastatin vs observation in Ki-67 positive, TAZ-expressing early breast cancer
2014-005508-62Phase 2Completed
- Sponsor
- Istituti Fisioterapici Ospitalieri
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in breast cancer and breast adenocarcinoma comparing Atorvastatin pre-surgical arm with Observation arm (2 arms). Primary endpoint: Ki-67 reduction below 15%. Started Jun 2021; status: completed.
02
Drugs
atorvastatin
03
Conditions
breast cancerbreast adenocarcinoma
Beyond the preview
Go deeper on 2014-005508-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005508-62.